SEC CIK 1446964
Daskal Ilan
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| VIAVview stock → | 94,566 | 2026-09-22 |
| BIOview stock → | 2,486.21 | 2023-09-02 |
Position History — BIO
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — BIO
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2023-09-02 | Option exercise (derivative) | 542 | $0.00 | 542 |
| 2023-09-02 | Tax withholding | 269 | $394.60 | 2,486.21 |
| 2023-09-02 | Option exercise | 542 | $0.00 | 2,755.21 |
| 2023-09-01 | Grant / award (derivative) | 4,007 | $0.00 | 4,007 |
| 2023-09-01 | Option exercise (derivative) | 694 | $0.00 | 2,082 |
| 2023-09-01 | Option exercise (derivative) | 456 | $0.00 | 912 |
| 2023-09-01 | Tax withholding | 209 | $394.60 | 2,213.21 |
| 2023-09-01 | Option exercise | 456 | $0.00 | 2,422.21 |
| 2023-09-01 | Tax withholding | 240 | $394.60 | 1,966.21 |
| 2023-09-01 | Option exercise | 694 | $0.00 | 2,206.21 |
| 2023-04-08 | Option exercise (derivative) | 700 | $0.00 | 700 |
| 2023-04-08 | Tax withholding | 243 | $466.24 | 1,493.27 |
| 2023-04-08 | Option exercise | 700 | $0.00 | 1,736.27 |
| 2022-09-02 | Option exercise (derivative) | 541 | $0.00 | 1,084 |
| 2022-09-02 | Tax withholding | 269 | $478.32 | 953 |
| 2022-09-02 | Option exercise | 541 | $0.00 | 1,222 |
| 2022-09-01 | Grant / award (derivative) | 2,776 | $0.00 | 2,776 |
| 2022-09-01 | Option exercise (derivative) | 455 | $0.00 | 1,368 |
| 2022-09-01 | Tax withholding | 226 | $486.25 | 681 |
| 2022-09-01 | Option exercise | 455 | $0.00 | 907 |
| 2022-04-08 | Option exercise (derivative) | 700 | $0.00 | 1,400 |
| 2022-04-08 | Option exercise | 700 | $0.00 | 709 |
| 2022-04-08 | Tax withholding | 257 | $597.16 | 452 |
| 2021-09-03 | Open-market sale | 270 | $820.06 | 9 |
| 2021-09-02 | Option exercise (derivative) | 541 | $0.00 | 1,625 |
| 2021-09-02 | Option exercise (derivative) | 540 | $0.00 | 1,626 |
| 2021-09-02 | Option exercise | 541 | $0.00 | 548 |
| 2021-09-02 | Option exercise | 540 | $524.30 | 547 |
| 2021-09-02 | Open-market sale | 440 | $828.00 | 107 |
| 2021-09-02 | Tax withholding | 269 | $825.77 | 279 |
| 2021-09-02 | Open-market sale | 100 | $828.01 | 7 |
| 2021-09-01 | Grant / award (derivative) | 1,823 | $0.00 | 1,823 |
| 2021-09-01 | Grant / award (derivative) | 1,823 | $0.00 | 1,823 |
| 2021-08-04 | Option exercise (derivative) | 1,400 | $0.00 | 2,100 |
| 2021-08-04 | Open-market sale | 857 | $750.85 | 1,450 |
| 2021-08-04 | Option exercise | 1,400 | $309.84 | 2,307 |
| 2021-08-04 | Open-market sale | 954 | $751.98 | 496 |
| 2021-08-04 | Open-market sale | 489 | $753.32 | 7 |
| 2021-04-08 | Option exercise (derivative) | 700 | $0.00 | 2,100 |
| 2021-04-08 | Option exercise | 700 | $0.00 | 1,157 |
| 2021-04-08 | Tax withholding | 250 | $592.23 | 907 |
| 2020-09-02 | Grant / award (derivative) | 2,166 | $0.00 | 2,166 |
| 2020-09-02 | Grant / award (derivative) | 2,166 | $0.00 | 2,166 |
| 2020-04-08 | Option exercise (derivative) | 700 | $0.00 | 2,800 |
| 2020-04-08 | Tax withholding | 243 | $403.06 | 457 |
| 2020-04-08 | Option exercise | 700 | $0.00 | 700 |
| 2019-04-08 | Grant / award (derivative) | 3,500 | $0.00 | 3,500 |
| 2019-04-08 | Grant / award (derivative) | 3,500 | $0.00 | 3,500 |
| 2019-04-06 | — | — | — | 0 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.